Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0043167 (
pertussis
)
19,595
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CART
peptides are important neurotransmitters, but little is known about their receptors or signaling pathways in cells. In this study we describe the effects of
CART
55-102 on the stimulation of extracellular signal-related kinase (ERK) in a pituitary-derived cell line.
CART
55-102 treatment resulted in markedly enhanced ERK phosphorylation in AtT20 and GH3 cells, but had no significant effect on ERK phosphorylation levels in a variety of other cell types that were examined. The peptide activated ERK1 and 2 in AtT20 cells in a dose- and time-dependent manner, but an inactive peptide,
CART
1-27, had no effect. U0126, an inhibitor of the MEK kinases, blocked the
CART
-stimulated activation of ERKs. ERK activation was also attenuated by
pertussis
toxin pre-treatment, but not by genistein, suggesting a Gi/o-dependent mechanism. Overall, these data strongly support the existence of a specific receptor for
CART
peptide that is a G-protein coupled receptor utilizing a Gi/o mechanism involving MEK1 and 2.
...
PMID:Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. 1590 20
Previous evidence obtained from several behavioral and biochemical studies suggested the existence of multiple
CART
receptors. However, identification of
CART
receptor binding has been largely unsuccessful until recently. The first evidence of
CART
signaling properties came from a study demonstrating that
CART
55-102 inhibited voltage-dependent intracellular calcium signaling. More recent studies showed
CART
-induced dose- and time-dependent activation of extracellular signal-regulated kinase (ERK) 1 and 2 in AtT20 cell line. The activation of ERK was blocked by
pertussis
toxin but not genisten suggesting the involvement of Gi/o linked cascade in
CART
's signaling properties in AtT20 cells. Shortly after these findings, the evidence of
CART
61-102 specific binding was obtained from the same cell line. This study demonstrated that [(125)I]-
CART
61-102 was displaced only by active
CART
peptide but not by inactive
CART
fragments or several other unrelated peptides or drugs. The [(125)I]-
CART
61-102 binding was saturable and it had a high affinity for a single site in AtT20 cells. The binding was also dependent on time, pH, temperature and protein concentration. The average (+/-S.E.M.) B(max) and K(d) values were 101.4+/-8.8 fmol/mg protein and 21.9+/-8.0 pM, respectively. These data indicate the existence of specific
CART
receptor binding in AtT20 cells where
CART
signaling has been demonstrated. The identification of a receptor clone in these cells may help us elucidate
CART
receptors in other tissues. Because
CART
is implicated with several physiological functions including feeding, drug reward and stress, identification of a
CART
receptor would provide a novel target for the development of pharmacological tools and drugs for obesity and other disorders.
...
PMID:The CART receptors: background and recent advances. 1671 58
The aim of this study was to investigate the effect of
CART
peptide on cardiac performance and on the physiological signalling pathways involved using Rana ridibunda frog heart preparations in vivo. The
CART
peptide, when injected into the venous sinus, significantly and reproducibly increased the force of frog heart contractions by up to 33.0 +/- 6.4% during the first 15 min after its application but did not influence the chronotropic activity of the frog heart. The positive inotropic effect was entirely blocked by prazosin,
pertussis
toxin, R(p)-adenosine 3',5'-cyclic monophosphorothioate, autosauvagine 30 or metyrapone, as well as by extirpation of the pituitary gland, functional elimination of the inter-renal glands and long-lasting starvation, and was not observed on isolated heart preparations. Propranolol and double pithing were without significant effect on this phenomenon. It was concluded that: (i)
CART
peptide, administered to frogs in vivo, increases the force of heart contractions; (ii) this effect of the peptide is exerted via activation of the hypothalamic-pituitary-inter-renal gland axis through a corticoliberin-sensitive mechanism; (iii)
CART
augments the pumping function of the heart via a corticosteroid-dependent potentiation of myocardial alpha(1)-adrenoreceptors signalling; and (iv) prolonged food deprivation abolishes the positive inotropic effect of
CART
, suggesting the participation of endogenous
CART
in the physiological adaptation of the circulatory system to limitations of energy consumption.
...
PMID:Cocaine- and amphetamine-regulated transcript (CART) peptide as an in vivo regulator of cardiac function in Rana ridibunda frog. 1772 Jul 43
CART
peptides are peptide neurotransmitters and hormones that are involved in many different physiological responses. While much is known about the peptides regarding their structure, processing and gene regulation, less is known about their postsynaptic actions and receptors. Using (125)I-
CART
61-102 as a ligand and unlabeled
CART
61-102 or
CART
55-102 as displacers, high-affinity specific binding was detected in PC12 cells. Differentiation of the PC12 cells increased specific binding several-fold. The increase in specific binding found after differentiation was inhibited by actinomycin D and cycloheximide, suggesting that the increase in specific binding was dependent on RNA and protein synthesis.
CART
1-27, a peptide that has never been shown to elicit responses, did not displace (125)I-
CART
61-102 binding, nor did more than 20 other peptides that were examined. Surprisingly, however, PACAP 1-38 and PACAP 6-38 were found to be low-affinity inhibitors of
CART
binding.
CART
treatment increased binding of (35)S-GTPgamma-S to PC12 cell membranes. Moreover,
CART
treatment of intact PC12 cells elicited robust increases in phospho-ERK in a manner that was increased with differentiation, blocked by
pertussis
toxin and antagonized by PACAP 6-38. These findings extend previous research and suggest that the
CART
binding site in PC12 cells reflects a G protein-coupled receptor linked with Gi/o, and also demonstrate that PACAP 6-38 may be useful as a
CART
receptor antagonist.
...
PMID:CART peptide stimulation of G protein-mediated signaling in differentiated PC12 cells: identification of PACAP 6-38 as a CART receptor antagonist. 2185 38
Although the role of
cocaine- and amphetamine-regulated transcript
peptide (CART) in modulating the mesolimbic reward pathway has been suggested, underlying cellular mechanisms have not been elucidated. Herein, we investigate the involvement of G
i/o
dependent protein kinase A (PKA)/extracellular signal-regulated kinase (ERK)/cAMP response element binding protein (CREB) signaling in CART induced reward behavior. The rat was implanted with a stimulating electrode targeted at the lateral hypothalamus (LH)-medial forebrain bundle (MFB) and conditioned to intracranial self-stimulation (ICSS) in an operant chamber. Intracerebroventricular (icv) administration of CART (55-102) dose-dependently lowered ICSS threshold suggesting reward promoting action, however, pretreatment with subeffective doses of G
i/o
inhibitor (
pertussis
toxin, PTX) or PKA inhibitor (Rp-cAMPS) or ERK inhibitor (U0126) via icv route, attenuated CART mediated reward experience. Operant conditioned rats showed increased pCREB levels in the nucleus accumbens shell (AcbSh), ventral tegmental area (VTA) and hypothalamic paraventricular nucleus (PVN). Infusion of CART (icv) in the conditioned rats augmented the population of pCREB positive cells in the AcbSh, VTA and PVN areas, but not in the arcuate nucleus (ARC). Pretreatment with U0126 significantly decreased CART induced pCREB activation in the AcbSh and VTA, but not in PVN and ARC. ICSS or CART induced CREB mRNA expression in Acb and VTA was attenuated by U0126. We suggest that recruitment of G
i/o
dependent PKA/ERK/CREB phosphorylation signaling in Acb and VTA might play an important role in CART induced reward behavior.
...
PMID:Cocaine- and amphetamine-regulated transcript peptide (CART) induced reward behavior is mediated via G
i/o
dependent phosphorylation of PKA/ERK/CREB pathway. 2958 Aug 92